3′-Sialyllactose alleviates bone loss by regulating bone homeostasis
Abstract Osteoporosis is a common skeletal disease that results in an increased risk of fractures. However, there is no definitive cure, warranting the development of potential therapeutic agents. 3′-Sialyllactose (3′-SL) in human milk regulates many biological functions. However, its effect on bone...
Main Authors: | Ahreum Baek, Dawoon Baek, Yoonhee Cho, Seongmoon Jo, Jinyoung Kim, Yoontaik Hong, Seunghee Cho, Sung Hoon Kim, Sung-Rae Cho |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-01-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-024-05796-4 |
Similar Items
-
3′-Sialyllactose Protects SW1353 Chondrocytic Cells From Interleukin-1β-Induced Oxidative Stress and Inflammation
by: Ahreum Baek, et al.
Published: (2021-04-01) -
Therapeutic effects of polydeoxyribonucleotide in an in vitro neuronal model of ischemia/reperfusion injury
by: Seongmoon Jo, et al.
Published: (2023-04-01) -
Very early environmental enrichment protects against apoptosis and improves functional recovery from hypoxic–ischemic brain injury
by: Hoo Young Lee, et al.
Published: (2023-02-01) -
High-Frequency Repetitive Magnetic Stimulation Enhances the Expression of Brain-Derived Neurotrophic Factor Through Activation of Ca2+–Calmodulin-Dependent Protein Kinase II–cAMP-Response Element-Binding Protein Pathway
by: Ahreum Baek, et al.
Published: (2018-05-01) -
Effect of Polydeoxyribonucleotide on Angiogenesis and Wound Healing in an Model of Osteoarthritis
by: Ahreum Baek, et al.
Published: (2018-11-01)